Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
N. Bekker (Groningen, Netherlands), A. Van Pijkeren (Groningen, Netherlands), J. Wolters (Groningen, Netherlands), A. Sánchez Brotons (Groningen, Netherlands), V. Guryev (Groningen, Netherlands), R. Bischoff (Groningen, Netherlands), W. Alkema (Groningen, Netherlands), M. Van Den Berge (Groningen, Netherlands), P. Horvatovich (Groningen, Netherlands), W. Timens (Groningen, Netherlands), C. Brandsma (Groningen, Netherlands). Proteomics approach to identify COPD-related changes in pulmonary fibroblasts. 1215

Member's Comments

No comment yet.

Related content which might interest you: microRNA profiling in pulmonary fibroblasts in COPD Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease Year: 2011 Use of pulmonary proteomics to investigate lung disease Source: Annual Congress 2004 - PG7 - Application of genomics and proteomics to pulmonary disease Year: 2004 Identifying tools to investigate outcomes following an exacerbation of COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Proteomic profiling identifies an exercise signature in patients with pulmonary arterial hypertension Source: Virtual Congress 2020 – Exercise and haemodynamics in pulmonary hypertension Year: 2020 Transcriptomic and epigenetic changes in the lung of patients with severe COPD Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Metabolomic signature in COPD. Plasma and lung tissue comparison identify sphingolipids as potential biomakers Source: International Congress 2014 – Markers Year: 2014 Differential response to pulmonary rehabilitation in COPD: multidimensional profiling Source: Eur Respir J 2015; 46: 1625-1635 Year: 2015 Application of omics technologies to the identification of biomarkers for COPD Source: Annual Congress 2007 - Cell biology of asthma and COPD Year: 2007 Biomarker discovery in chronic obstructive pulmonary disease (COPD) using epithelial lining fluid: A proteomic approach Source: Annual Congress 2011 - Phenotyping airway diseases Year: 2011 Combined genome-wide transcriptomic and epigenetic profiling across disease stages identifies novel regulators of COPD in human lung fibroblasts Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies Year: 2020 iTRAQ-based proteomic analysis reveals mitochondrial 'damage'-associated molecular patterns are involved in pulmonary inflammation in Lypopolysaccharide-induced acute lung injury Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury Year: 2018 Tools used to measure airway remodelling in research Source: Eur Respir J 2007; 29: 596-604 Year: 2007 A functional imaging study to investigate the relationship between pulmonary inflammation and systemic inflammation in COPD patients Source: International Congress 2016 – From microimaging to functional evaluation of the lung Year: 2016 Gene expression signatures in airway and nasal epithelium of COPD: linking endotypes to clinical outcomes Source: International Congress 2017 – Heterogeneity in COPD inflammation: implications for therapy and clinical outcomes Year: 2017 Home monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and progression: a systematic review Source: ERJ Open Res, 7 (4) 00441-2021; 10.1183/23120541.00441-2021 Year: 2021 Dynamic hyperinflation, pulmonary inflammation and AECOPD: a potentially relevant relationship? Source: Research Seminar 2011 - Physical activity, nutritional status and systemic inflammation in COPD Year: 2011 Domiciliary monitoring of physiology and symptoms to detect interstitial lung disease exacerbations and/or progression: a systematic review Source: Virtual Congress 2021 – Prognostic markers of disease progression in non-idiopathic pulmonary fibrosis interstitial lung diseases Year: 2021 A network-based approach to defining phenotypes in COPD Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 Plasma metabolomic signature in COPD patients: Associations to proteomic profile and clinical outcomes Source: Annual Congress 2013 –COPD mechanisms Year: 2013 The effectiveness of pulmonary rehabilitation in interstitial lung diseases in terms of functional markers Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)? Year: 2018